National Biopharma Mission Program by BIRAC
BIRAC Announces Call for Proposals under National Biopharma Mission Program
2018 Call
National Biopharma Mission invites Proposals for Good Clinical Laboratory Practice (GCLP) lab and Translation Research Consortium (TRC)
Advt.
Request for Proposals (RFPs)
Last date for Submission:
Good Clinical Laboratory Practice (GCLP) lab : 15th August, 2018
Translation Research Consortium (TRC): 31st August, 2018
INTRODUCTION 2017
National Biopharma Mission Program: An Industry-Academia Collaborative Mission of Department of Biotechnology (DBT) for Accelerating Early Development for Biopharmaceuticals; to be implemented by Biotechnology Research Assistance Council (BIRAC)-a Public Sector Undertaking of DBT.
The National Biopharma Mission was approved by the Cabinet for implementation in May 2017 with a total cost US$ 250 million which is co-funded by World Bank 50%.
Mission of the Programme:
To enable and nurture an ecosystem for preparing India’s technological and product development capabilities in biopharmaceuticals to a level that will be globally competitive over the next decade, and transform the health standards of India’s population through affordable product development
KEY FEATURES OF THE CALL
Focus of the Call:
1. Biotherapeutics:
This Request for Proposals (RFP) is to seek individual applications on either of the following:
Development of 2-3 biosimilar (therapeutic proteins and monoclonal antibodies for cancer, rheumatoid arthritis and diabetes)
Process Development Laboratory
CMC Facility
GLP Validation Facility
Cell Line Repository for providing access to cell lines
2. Vaccines:
Development of vaccine candidates for HPV, Dengue and other emerging infections in development.
GCLP Lab for characterization, evaluation and validation of vaccines in clinical stages
Translational Research Consortia to improve, standardize and provide support for discovery, development and evaluation vaccine and monoclonal antibodies.
3. Medical Devices & Diagnostics:
Development of 2-3 critical medical device technologies that are currently under development by the industry and bring them closer to the market in 3 years.
WHO CAN APPLY?
Legal eligible Proponents
The proposals can be submitted by:
Solely by an Indian Company or
Jointly by an Indian Company and National R&D Organizations and Institutions; or
By a Consortium of Indian Companies along with National Research Organizations etc.
Criteria Particulars for the Proponent entities
Indian companies
An Indian Company is defined as one which is registered under the Indian Companies Act, 2013 and minimum 51% of the shares of the Company should be held by Indian Citizens holding Indian passport (Indian Citizens do not include Person of Indian Origin (PIO) and Overseas Citizenship of India (OCI) holders
Non-profit organizations/ Government entities/ Institutes/ R&D Organizations
This will include Academic Research Institutes, Universities, Research Foundation, Medical Colleges and Institutes – both public and private who are valid legal entities such as Trust, Society or established under central or state statute.
DBT/BIRAC reserves the right not to process your Proposal should you be ineligible to be a Proponent or should the subject of your proposal not fall within the RFPs’ remit. Mere consideration of the Proposal in no way implies that sanction of Grant-in-aid will be forthcoming.
HOW TO APPLY?
Proposals are required to be submitted online only. For submission of proposals, applicants need to register with BIRAC through “User Registration”. Additional information on user registration and proposal submission are available online at BIRAC website at www.birac.nic.in.
No Hard Copy to be submitted. Proposals submitted online only would be considered.
Last date for Submission of Proposals: 15th December 2017
BIRAC will ensure maintenance of strict confidentiality of the proposals as per DBT norms.